Total Payments
$1,945
2024 Payments
$293.60
Companies
27
Transactions
97
Payment Breakdown by Category
Food & Beverage$1,772 (91.1%)
Education$173.68 (8.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,772 | 84 | 91.1% |
| Education | $173.68 | 13 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $446.93 | 20 | $0 (2024) |
| Dexcom, Inc. | $177.69 | 9 | $0 (2023) |
| Tolmar, Inc. | $174.24 | 12 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $117.79 | 7 | $0 (2024) |
| Ascendis Pharma Inc | $100.07 | 3 | $0 (2024) |
| ABBVIE INC. | $96.69 | 4 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $92.37 | 4 | $0 (2019) |
| PFIZER INC. | $92.26 | 5 | $0 (2024) |
| Lilly USA, LLC | $89.74 | 6 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $67.23 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.60 | 12 | ABBVIE INC. ($42.91) |
| 2023 | $344.73 | 18 | Tolmar, Inc. ($145.10) |
| 2022 | $83.81 | 2 | Ascendis Pharma, Inc. ($60.45) |
| 2020 | $28.89 | 2 | AbbVie Inc. ($14.58) |
| 2019 | $397.60 | 21 | Novo Nordisk Inc ($117.10) |
| 2018 | $361.50 | 21 | Novo Nordisk Inc ($132.83) |
| 2017 | $435.15 | 21 | Novo Nordisk Inc ($175.83) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/19/2024 | Sequel Med Tech, LLC | — | Food and Beverage | In-kind items and services | $20.78 | General |
| 09/17/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $42.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/20/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Growth Hormone | ||||||
| 07/16/2024 | Endo USA, Inc. | SUPPRELIN (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/18/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/16/2024 | Tolmar, Inc. | FENSOLVI (Drug) | Food and Beverage | Cash or cash equivalent | $29.14 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 04/06/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Automated insulin delivery system | ||||||
| 02/27/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Endocrinology | ||||||
| 02/20/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes Care | ||||||
| 01/16/2024 | PFIZER INC. | GENOTROPIN (Drug), NGENLA | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 10/23/2023 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $56.05 | General |
| 10/17/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: Endocrinology | ||||||
| 09/20/2023 | Ascendis Pharma Inc | SKYTROFA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Endocrinology | ||||||
| 08/15/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/18/2023 | Tolmar, Inc. | JATENZO (Drug), FENSOLVI | Education | In-kind items and services | $63.70 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $42.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $11.15 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $5.80 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $4.15 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $3.63 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $1.86 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $1.02 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 07/18/2023 | Tolmar, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $0.74 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
About Dr. William Lagarde, MD
Dr. William Lagarde, MD is a Pediatric Endocrinology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811077837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Lagarde, MD has received a total of $1,945 in payments from pharmaceutical and medical device companies, with $293.60 received in 2024. These payments were reported across 97 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($1,772).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Raleigh, NC
- Active Since 10/16/2006
- Last Updated 03/04/2021
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1811077837
Products in Payments
- Tresiba (Drug) $156.26
- Norditropin (Drug) $153.42
- FENSOLVI (Drug) $110.54
- Dexcom CGM (Device) $94.80
- t-slim insulin pump (Device) $92.37
- GENOTROPIN (Drug) $92.26
- SKYTROFA (Drug) $79.96
- Triptodur (Drug) $67.23
- JATENZO (Drug) $63.70
- LANTUS (Drug) $61.49
- LUPRON DEPOT (Drug) $57.49
- Dexcom G6 Transmitter (Medical Supply) $56.23
- NASCOBAL (Drug) $45.84
- HUMALOG (Drug) $45.21
- Minimed 670G System (Device) $44.11
- TZIELD (Biological) $42.22
- Nutropin AQ (Biological) $30.91
- Levemir (Drug) $27.84
- DEXCOM CGM (Device) $26.66
- HUMATROPE (Drug) $25.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.